Investigating the multi-target pharmacological mechanism of wendan decoction in the treatment of schizophrenia

Lei Li,Jing Liu,Hongjun Ye,Kan Qin
DOI: https://doi.org/10.1016/j.hermed.2023.100707
IF: 2.542
2023-07-30
Journal of Herbal Medicine
Abstract:Introduction Wendan decoction (WDD) has been used to treat schizophrenia with a considerable effect of improving depressive and manic psychosis. It was considered as a multi-target drug. This study was the first attempt to identify the multi-target pharmacological ‎mechanism of WDD to treat schizophrenia using scientific databases. Methods The databases of PubChem, Traditional Chinese Medicine Systems Pharmacology (TCMSP) and Wanfang data were used to screen the active ingredients of WDD. The prediction of targets was carried out using the Swiss Target Prediction network database (SWISS) and analyzed with the targets associated with schizophrenia by Cytoscape. Finally, the key targets were ranked according to relevant node parameters obtained by the pathway enrichment. Results The findings showed that the potential activity might be from quercetin, licochalcone A, stigmasterol, etc. The targets of the disease are mainly based on amyloid beta (A4) precursor protein (APP), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), cholinergic receptor muscarinic 2 (CHRM2), etc. Quercetin can participate in neural development and synaptic plasticity by regulating the PI3K/ART pathway in schizophrenia (SZ). Results of functional enrichment analysis suggest that WDD exerts its pharmacological effects in SZ through multifaceted functional regulation, including the neuroactive ligand-receptor interaction, cAMP signaling pathway, serotonergic synapse, dopaminergic synapse and inflammatory mediator regulation of transient receptor potential (TRP) channels. Conclusion The WDD treats the SZ by influencing the neurodevelopment, modulating the neurotransmitters and enhancing the antipsychotics. It provides a new approach to revealing the molecular therapeutic mechanisms of the WDD in treating SZ by network pharmacology analysis.
integrative & complementary medicine
What problem does this paper attempt to address?